Corporate Vectors of Chronic Disease — Using Internal Industry Documents to Craft Counterstrategies

New England Journal of Medicine 2026

View at publisher
Authors: Consortium of the Center to End Corporate Harm, University of California, San Francisco
DOI: 10.1056/nejmms2507028
Cited by: 4
References: 33

Abstract

Corporations that make and market health-harming products are a primary vector for the global increase in mortality related to noncommunicable diseases. Research using internal industry documents can help.

Fields of Study & Subjects

Pharmaceutical industry and healthcare Global Public Health Policies and Epidemiology Biomedical Ethics and Regulation

Publication details

Journal / source
New England Journal of Medicine
Publisher
Massachusetts Medical Society
Volume
394
Issue
12
Pages
1231–1237
Publication date
25 March 2026
Language
EN